Literature DB >> 30790465

Structure-Activity Relationship Studies of the Natural Product Gq/11 Protein Inhibitor YM-254890.

Xiao-Feng Xiong1,2, Hang Zhang1,3, Michael W Boesgaard1, Christina R Underwood1, Hans Bräuner-Osborne1, Kristian Strømgaard1.   

Abstract

G proteins act as molecular switches in G protein-coupled receptor signaling pathways and are key mediators for numerous important physiological processes. The natural product, cyclic depsipeptide YM-254890, together with the structurally similar FR900359, is the only known selective inhibitor of the Gq/11 subfamily of G proteins. We recently reported the first total synthesis of YM-254890 and FR900359, followed by synthesizing analogues to perform structure-activity relationship studies. However, incomplete information about their structure-activity relationship prevents the further development of potent and structurally simplified analogues. Herein we report the first systematic structure-activity relationship study toward the N-methyldehydroalanine moiety in YM-254890, by designing and synthesizing seven new analogues. Pharmacological characterization of the seven compounds for Gq/11 -, Gi/o - and Gs -mediated signaling showed that the simplified analogue YM-19 is the most potent Gq/11 inhibitor among the new analogues. This study provides information for the future design of potent and simplified YM-254890 analogues.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  G protein inhibitors; G protein-coupled receptors; G proteins; YM-254890; structure-activity relationships

Year:  2019        PMID: 30790465     DOI: 10.1002/cmdc.201900018

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  7 in total

1.  Delineation of molecular determinants for FR900359 inhibition of Gq/11 unlocks inhibition of Gαs.

Authors:  Michael W Boesgaard; Kasper Harpsøe; Michelle Malmberg; Christina R Underwood; Asuka Inoue; Jesper M Mathiesen; Gabriele M König; Evi Kostenis; David E Gloriam; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

Review 2.  GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma.

Authors:  Paula Silva-Rodríguez; Daniel Fernández-Díaz; Manuel Bande; María Pardo; Lourdes Loidi; María José Blanco-Teijeiro
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

3.  Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?

Authors:  Jonathan G Schlegel; Mariam Tahoun; Alexander Seidinger; Jan H Voss; Markus Kuschak; Stefan Kehraus; Marion Schneider; Michaela Matthey; Bernd K Fleischmann; Gabriele M König; Daniela Wenzel; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-19

4.  Editorial to Special Issue-"Structure-Activity Relationships (SAR) of Natural Products".

Authors:  Wolfgang Sippl; Fidele Ntie-Kang
Journal:  Molecules       Date:  2021-01-06       Impact factor: 4.411

5.  Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359.

Authors:  Cornelia Hermes; René Richarz; Daniel A Wirtz; Julian Patt; Wiebke Hanke; Stefan Kehraus; Jan Hendrik Voß; Jim Küppers; Tsubasa Ohbayashi; Vigneshwaran Namasivayam; Judith Alenfelder; Asuka Inoue; Peter Mergaert; Michael Gütschow; Christa E Müller; Evi Kostenis; Gabriele M König; Max Crüsemann
Journal:  Nat Commun       Date:  2021-01-08       Impact factor: 17.694

6.  Cell-permeable high-affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors.

Authors:  Markus Kuschak; Vigneshwaran Namasivayam; Muhammad Rafehi; Jan H Voss; Jaspal Garg; Jonathan G Schlegel; Aliaa Abdelrahman; Stefan Kehraus; Raphael Reher; Jim Küppers; Katharina Sylvester; Sonja Hinz; Michaela Matthey; Daniela Wenzel; Bernd K Fleischmann; Alexander Pfeifer; Asuka Inoue; Michael Gütschow; Gabriele M König; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

Review 7.  Targeting Oncogenic Gαq/11 in Uveal Melanoma.

Authors:  Dominic Lapadula; Jeffrey L Benovic
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.